Raymond James Starts Nivalis Therapeutics (NVLS) at Outperform

September 13, 2016 6:51 AM EDT
Get Alerts NVLS Hot Sheet
Price: $6.12 -5.56%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 27 | New: 7
Trade NVLS Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Raymond James initiated coverage on Nivalis Therapeutics (NASDAQ: NVLS) with an Outperform rating and a price target of $20.00.

For an analyst ratings summary and ratings history on Nivalis Therapeutics click here. For more ratings news on Nivalis Therapeutics click here.

Shares of Nivalis Therapeutics closed at $7.77 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hot New Coverage, New Coverage

Related Entities

Raymond James

Add Your Comment